机器人胆囊切除术与腹腔镜胆囊切除术的择期手术结局比较:ROBOCOP项目
基于美国医院电子健康记录数据,比较2020至2022年择期机器人胆囊切除术(RCHOLE,n=23,581)与腹腔镜胆囊切除术(LCHOLE,n=93,122)的临床结局。经多变量逻辑回归联合逆概率治疗加权校正后,RCHOLE中转开腹的比值更低(OR 0.51),再入院、医院获得性情况及胆管损伤的比值亦更低,但手术时间更长。
要点
- 择期RCHOLE中转开腹的比值显著低于LCHOLE(OR 0.51)。
- RCHOLE再入院和医院获得性情况的比值低于LCHOLE。
- RCHOLE手术时间更长(107±53 vs 93±42分钟)。
核心结论
- 择期机器人胆囊切除术相比腹腔镜胆囊切除术,中转开腹、再入院和医院获得性情况(包括胆管损伤)的比值更低。
研究设计与样本
- 研究获非人类受试者研究认定,使用Intuitive Custom Hospital Analytics数据库去标识化提取的美国医院电子健康记录数据,纳入2020至2022年择期LCHOLE(n=93,122)和RCHOLE(n=23,581)病例。
- 排除手术时间和人口学数据缺失的患者(n=11,276),采用多变量逻辑回归联合逆概率治疗加权平衡协变量,使用R 4.1.1分析。
主要发现
- RCHOLE患者肥胖比例更高(BMI≥30 kg/m2,38.0% vs 33.4%,p<0.001),手术时间更长(107±53 vs 93±42分钟,p<0.001)。
- 经MLR/IPTW校正后,RCHOLE中转开腹的比值降低(OR 0.51 [95%CI 0.42, 0.61],p<0.001),中转 subtotal 胆囊切除术的比值相似。
- RCHOLE再入院(OR 0.89 [95%CI 0.81, 0.97],p=0.008)、医院获得性情况(OR 0.71 [95%CI 0.60, 0.83],p<0.001)和胆管损伤(OR 0.00,p<0.001)的比值更低。
- 手术部位感染和住院死亡率的比值在两组间相似。
临床怎么用
- 择期胆囊切除术中,机器人入路可考虑用于降低中转开腹及胆管损伤等风险,但需权衡更长的手术时间。
局限性
- 研究基于行政编码数据识别病例和结局,可能存在编码偏倚。
- 为回顾性观察性研究,尽管采用MLR/IPTW校正,仍可能存在未测量混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robotic cholecystectomy (RCHOLE) is being used more frequently for elective patients. We aimed to compare clinical outcomes, specifically conversion to open/subtotal cholecystectomy, for RCHOLE and laparoscopic cholecystectomy (LCHOLE). METHODS: Our study received a Non-Human Subjects Research Determination. We studied elective laparoscopic (LCHOLE) and robotic (RCHOLE) cases from 2020 to 2022 using de-identified extraction of electronic US hospital health record data from the Intuitive Custom Hospital Analytics database. LCHOLE and RCHOLE cases, conversion to open/subtotal cholecystectomy, and complications were identified using ICD10 and/or CPT codes. Patients with missing operative times and demographics were excluded (n = 11,276). We used Multivariate Logistic Regression with Inverse Probability Treatment Weighting(MLR/IPTW) to balance covariates. R 4.1.1 was used for analysis. RESULTS: LCHOLE(n = 93,122) and RCHOLE(n = 23,581) had similar mean age(50 years) and gender(70% female); RCHOLE patients were more frequently obese(BMI ≥ 30 kg/m2, 38.0% vs. 33.4%, p < 0.001). Operative time was longer in RCHOLE(107 ± 53 vs. 93 ± 42 min, p < 0.001). After MLR/IPTW, RCHOLE had decreased odds of conversion to open cholecystectomy (OR 0.51 [95%CI 0.42, 0.61, p < 0.001), but similar odds of subtotal cholecystectomy. Readmission (OR 0.89 [0.81, 0.97, p = 0.008]) hospital acquired conditions (OR 0.71 [0.60, 0.83, p < 0.001]), and bile duct injury (OR 0.00, p < 0.001) were less likely with RCHOLE. Odds of surgical site infection and hospital mortality were similar in both groups. CONCLUSIONS: In the elective setting, robotic cholecystectomy has reduced odds of conversion to open, readmission, and hospital acquired conditions including bile duct injury when compared to laparoscopic cholecystectomy.
引用
- Abou Assali M, Li Y, Bossie H, et al. Robotic Care Outcomes Project (ROBOCOP) for elective cholecystectomy. Surg Endosc. 2025. PMID: 40858944. doi:10.1007/s00464-025-12109-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。